Novel Spirooxindole–Benzofuran Scaffold: Potential Inhibition Against Hepatocellular Carcinoma by Targeting MDM2‐p53 Interaction

Abstract We synthesized a novel compound library featuring a spirooxindole core structure combined with various heterocycles, including benzofuran, benzothiophene, and thiophene scaffolds. Evaluation using MTT assays against HepG2, 4T1, and MDA‐MB‐231 cells revealed the most potent candidate, spirooxindole hybrid 5c , with an IC50 of 5 ± 0.6 µM against HepG2, inducing G2/M phase cell cycle arrest, inhibition of the wound healing, and induction of ROS. Selected spirooxindole conjugates exhibited significant inhibitory potential against MDM2, with KD values ranging from 0.0531 to 16.8 µM. Notably, the salt of spirooxindole analogue 5q demonstrated the highest inhibitory activity at K D = 53.1 nM. Molecular docking studies revealed excellent accommodation of the designed compounds within the MDM2 receptor. All compounds displayed favorable ADME profiles, suggesting their potential as lead compounds for further optimization.

Authors

Institutions

Publication Details

Journal
ChemistrySelect
Published
2024-12-01
DOI
https://doi.org/10.1002/slct.202403953
Citations
2
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.57

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Spirooxindole–Benzofuran Scaffold: Potential Inhibition Against Hepatocellular Carcinoma by Targeting MDM2‐p53 Interaction

Muhanna K. Al‐Muhanna, Komal Zia, Assem Barakat, Mohammad Shahidul Islam et al.
2 citations
ChemistrySelect
Cancer-related Molecular Pathways
0.57
article

Novel Spirooxindole–Benzofuran Scaffold: Potential Inhibition Against Hepatocellular Carcinoma by Targeting MDM2‐p53 Interaction

Muhanna K. Al‐Muhanna, Komal Zia, Assem Barakat, Mohammad Shahidul Islam, Fardous F. El‐Senduny, Mohd Sajid Ali, Alexander Dömlingꝉ, Farid A. Badria, Zaheer Ul‐Haq, Abdulmajeed Abdullah Alayyaf
article en
2 citations

Abstract

Abstract We synthesized a novel compound library featuring a spirooxindole core structure combined with various heterocycles, including benzofuran, benzothiophene, and thiophene scaffolds. Evaluation using MTT assays against HepG2, 4T1, and MDA‐MB‐231 cells revealed the most potent candidate, spirooxindole hybrid 5c , with an IC50 of 5 ± 0.6 µM against HepG2, inducing G2/M phase cell cycle arrest, inhibition of the wound healing, and induction of ROS. Selected spirooxindole conjugates exhibited significant inhibitory potential against MDM2, with KD values ranging from 0.0531 to 16.8 µM. Notably, the salt of spirooxindole analogue 5q demonstrated the highest inhibitory activity at K D = 53.1 nM. Molecular docking studies revealed excellent accommodation of the designed compounds within the MDM2 receptor. All compounds displayed favorable ADME profiles, suggesting their potential as lead compounds for further optimization.

ChemistrySelectVol. 9(46)
King Abdulaziz City for Science and Technology (SA), Mansoura University (EG), University of Karachi (PK), King Saud University (SA), International Center for Chemical and Biological Sciences (PK), Institute of Molecular and Translational Medicine (CZ), Sylvester Comprehensive Cancer Center (US), Palacký University Olomouc (CZ)
King Saud University, Science and Technology Development Fund, KWF Kankerbestrijding, King Abdulaziz City for Science and Technology
Good health and well-being
Openalex Percentile: Top 26%
Cancer-related Molecular Pathways
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.